BSD Medical has featured its hyperthermia product line at International Congress of Hyperthermic Oncology (ICHO), which was held as a joint conference with the Japanese Congress of Thermal Medicine in Kyoto, Japan, in 2012.

BSD’s equipment utilizes heat therapy to treat various forms of tumors including sarcoma, prostate, pancreatic, head and neck, breast, cervical, and pelvic cancers.

Clinical studies have demonstrated an improved outcome from the addition of hyperthermia, delivered using BSD’s equipment, to radiotherapy and/or chemotherapy, for the treatment of various forms of cancer.

BSD Medical president Harold Wolcott said the company met with key hyperthermia researchers and clinicians during the conference.

"We are pleased with the level of interest in hyperthermia shown by both the U.S. and the international medical community and distributors," Wolcott added.

"Attendance at this international conference allowed the Company to build worldwide awareness of BSD’s hyperthermia products."